ArticleBMC complementary medicine and therapies2023

Fumigaclavine C ameliorates liver steatosis by attenuating hepatic de novo lipogenesis via modulation of the RhoA/ROCK signaling pathway.

Wanguo Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.